PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
Vigil Neuroscience, Inc. (VIGL)
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Company Info

ISIN

US92673K1088

CUSIP

92673K108

Sector

Healthcare

IPO Date

Jan 7, 2022

Highlights

Market Cap

$116.51M

EPS (TTM)

-$2.07

Gross Profit (TTM)

-$226.00K

EBITDA (TTM)

-$64.23M

Year Range

$1.49 - $6.06

Target Price

$16.19

Short %

6.90%

Short Ratio

0.73

Share Price Chart


Loading data...

Compare to other instruments

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Popular comparisons:
VIGL vs. VOO VIGL vs. SPY VIGL vs. VIVAX VIGL vs. VYM VIGL vs. VTV VIGL vs. POAGX VIGL vs. VXUS VIGL vs. XLG VIGL vs. SCHD
Popular comparisons:
VIGL vs. VOO VIGL vs. SPY VIGL vs. VIVAX VIGL vs. VYM VIGL vs. VTV VIGL vs. POAGX VIGL vs. VXUS VIGL vs. XLG VIGL vs. SCHD

Performance

Performance Chart

The chart shows the growth of an initial investment of $10,000 in Vigil Neuroscience, Inc., comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.


-60.00%-50.00%-40.00%-30.00%-20.00%-10.00%0.00%10.00%SeptemberOctoberNovemberDecember2025February
-21.69%
9.31%
VIGL (Vigil Neuroscience, Inc.)
Benchmark (^GSPC)

Returns By Period

Vigil Neuroscience, Inc. had a return of 67.65% year-to-date (YTD) and -8.36% in the last 12 months.


VIGL

YTD

67.65%

1M

47.67%

6M

-21.70%

1Y

-8.36%

5Y*

N/A

10Y*

N/A

^GSPC (Benchmark)

YTD

4.46%

1M

2.46%

6M

9.31%

1Y

23.49%

5Y*

13.03%

10Y*

11.31%

*Annualized

Monthly Returns

The table below presents the monthly returns of VIGL, with color gradation from worst to best to easily spot seasonal factors. Returns are adjusted for dividends.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
202540.00%67.65%
2024-19.53%27.94%-2.01%-23.46%21.84%25.79%4.25%-16.55%-2.30%11.18%-34.66%-31.17%-49.70%
2023-13.28%10.70%-18.42%-11.13%14.94%-6.00%-13.40%-25.92%-10.61%29.87%-54.57%6.29%-72.96%
20221.98%31.47%-58.55%-51.78%-14.16%-11.34%157.75%29.32%5.81%72.31%-20.28%-0.00%-1.19%

Risk-Adjusted Performance

Risk-Adjusted Performance Rank

The current rank of VIGL is 42, indicating average performance compared to other stocks on our website. Here’s a breakdown of how it compares using common performance measures.


The Risk-Adjusted Performance Rank of VIGL is 4242
Overall Rank
The Sharpe Ratio Rank of VIGL is 4040
Sharpe Ratio Rank
The Sortino Ratio Rank of VIGL is 4848
Sortino Ratio Rank
The Omega Ratio Rank of VIGL is 4545
Omega Ratio Rank
The Calmar Ratio Rank of VIGL is 3838
Calmar Ratio Rank
The Martin Ratio Rank of VIGL is 3838
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

Risk-Adjusted Performance Indicators

The charts below present risk-adjusted performance metrics for Vigil Neuroscience, Inc. (VIGL) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.


Sharpe ratio
The chart of Sharpe ratio for VIGL, currently valued at -0.12, compared to the broader market-2.000.002.00-0.121.74
The chart of Sortino ratio for VIGL, currently valued at 0.58, compared to the broader market-4.00-2.000.002.004.006.000.582.35
The chart of Omega ratio for VIGL, currently valued at 1.07, compared to the broader market0.501.001.502.001.071.32
The chart of Calmar ratio for VIGL, currently valued at -0.14, compared to the broader market0.002.004.006.00-0.142.61
The chart of Martin ratio for VIGL, currently valued at -0.40, compared to the broader market0.0010.0020.0030.00-0.4010.66
VIGL
^GSPC

The current Vigil Neuroscience, Inc. Sharpe ratio is -0.12. This value is calculated based on the past 1 year of trading data and takes into account price changes and dividends.

Use the chart below to compare the Sharpe ratio of Vigil Neuroscience, Inc. with the selected benchmark, providing insights into the investment's historical performance in terms of risk-adjusted returns. Go to the Sharpe ratio tool for more fine-grained control over the calculation options.


Rolling 12-month Sharpe Ratio-1.000.001.002.003.00SeptemberOctoberNovemberDecember2025February
-0.12
1.74
VIGL (Vigil Neuroscience, Inc.)
Benchmark (^GSPC)

Dividends

Dividend History


Vigil Neuroscience, Inc. doesn't pay dividends

Drawdowns

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.


-100.00%-80.00%-60.00%-40.00%-20.00%0.00%SeptemberOctoberNovemberDecember2025February
-83.52%
0
VIGL (Vigil Neuroscience, Inc.)
Benchmark (^GSPC)

Worst Drawdowns

The table below displays the maximum drawdowns of the Vigil Neuroscience, Inc.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Vigil Neuroscience, Inc. was 91.15%, occurring on Dec 30, 2024. The portfolio has not yet recovered.

The current Vigil Neuroscience, Inc. drawdown is 83.52%.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-91.15%Feb 17, 2022720Dec 30, 2024
-11.95%Jan 31, 20221Jan 31, 20228Feb 10, 20229
-9.8%Jan 10, 20221Jan 10, 20222Jan 12, 20223
-3%Jan 24, 20221Jan 24, 20224Jan 28, 20225
-0.71%Jan 13, 20221Jan 13, 20221Jan 14, 20222

Volatility

Volatility Chart

The current Vigil Neuroscience, Inc. volatility is 20.95%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.


0.00%10.00%20.00%30.00%40.00%SeptemberOctoberNovemberDecember2025February
20.95%
3.07%
VIGL (Vigil Neuroscience, Inc.)
Benchmark (^GSPC)

Financials

Financial Performance

The chart below illustrates the trends in the financial health of Vigil Neuroscience, Inc. over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.

Annual
Quarterly

0.0

Historical P/E Ratio Chart

The chart below displays the historical trend of the price-to-earnings (P/E) ratio for Vigil Neuroscience, Inc..


Loading data...

Income Statement



TTM
Revenue

Total Revenue

Cost Of Revenue

Gross Profit

Operating Expenses

Selling, General & Admin Expenses

R&D Expenses

Depreciation And Amortization

Total Operating Expenses

Income

Income Before Tax

Operating Income

EBITDA

EBIT

Earnings From Continuing Operations

Net Income

Income Tax Expense

Other Non-Operating Income (Expenses)

Extraordinary Items

Discontinued Operations

Effect Of Accounting Charges

Non Recurring

Minority Interest

Other Items

Interest Income

Interest Expense

Net Interest Income

Values in undefined except per share items
PortfoliosLab logo
Performance Analysis
Portfolio AnalysisPortfolio PerformanceStock ComparisonSharpe RatioMartin RatioTreynor RatioSortino RatioOmega RatioCalmar RatioSummers Ratio
Community
Discussions


Disclaimer

The information contained herein does not constitute investment advice and made available for educational purposes only. Prices and returns on equities are listed without consideration of fees, commissions, taxes, penalties, or interest payable due to purchasing, holding, or selling.

Copyright © 2025 PortfoliosLab